Gene · 57016
Papers1,760
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,760
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Exploring the ethnopharmacological significance of Cynara scolymus bracts: Integrating metabolomics, in-Vitro cytotoxic studies and network pharmacology for liver and breast anticancer activity assessment. | J Ethnopharmacol | 2024 | 39013541 | PubTator, text mining | PubMed |
| The Role of AKR1B10 in Lung Cancer Malignancy Induced by Sublethal Doses of Chemotherapeutic Drugs. | Cancers (Basel) | 2024 | 39001490 | PubTator, text mining | PubMed |
| Effects of tea infusion on selenium uptake in grapevine. | BMC Plant Biol | 2024 | 38987701 | PubTator, text mining | PubMed |
| Nicotinate-curcumin improves NASH by inhibiting the AKR1B10/ACCα-mediated triglyceride synthesis. | Lipids Health Dis | 2024 | 38937844 | PubTator, text mining | PubMed |
| Chlorogenic Acid as a Potential Therapeutic Agent for Cholangiocarcinoma. | Pharmaceuticals (Basel) | 2024 | 38931461 | PubTator, text mining | PubMed |
| Understanding the heterogeneity in liver hepatocellular carcinoma with a special focus on malignant cell through single-cell analysis. | Discov Oncol | 2024 | 38913193 | PubTator, text mining | PubMed |
| Secukinumab and Dead Sea Climatotherapy Impact Resolved Psoriasis Skin Differently Potentially Affecting Disease Memory. | Int J Mol Sci | 2024 | 38892277 | PubTator, text mining | PubMed |
| AKR1B10 expression characteristics in hepatocellular carcinoma and its correlation with clinicopathological features and immune microenvironment. | Sci Rep | 2024 | 38802416 | PubTator, text mining | PubMed |
| Anticancer Effects of Wild Baicalin on Hepatocellular Carcinoma: Downregulation of AKR1B10 and PI3K/AKT Signaling Pathways. | Cancer Manag Res | 2024 | 38800664 | PubTator, text mining | PubMed |
| Role of AKR1B10 in inflammatory diseases. | Scand J Immunol | 2024 | 38769661 | PubTator, text mining | PubMed |
| Berberine directly targets AKR1B10 protein to modulate lipid and glucose metabolism disorders in NAFLD. | J Ethnopharmacol | 2024 | 38762210 | PubTator, text mining | PubMed |
| Machine learning-based algorithm identifies key mitochondria-related genes in non-alcoholic steatohepatitis. | Lipids Health Dis | 2024 | 38720280 | PubTator, text mining | PubMed |
| CHES1 modulated tumorigenesis and senescence of pancreas cancer cells through repressing AKR1B10. | Biochim Biophys Acta Mol Basis Dis | 2024 | 38718846 | PubTator, text mining | PubMed |
| A Novel lncRNA lncRNA-4045 Promotes the Progression of Hepatocellular Carcinoma by Affecting the Expression of AKR1B10. | Dig Dis Sci | 2024 | 38662158 | PubTator, text mining | PubMed |
| A novel prognostic signature based on cancer stemness and metabolism-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma. | Aging (Albany NY) | 2024 | 38656879 | PubTator, text mining | PubMed |
| A Novel Four‑Gene Biomarker for Tobacco Smoking-Induced Colorectal Cancer Progression. | Nicotine Tob Res | 2024 | 38602278 | PubTator, text mining | PubMed |
| NRF2 activation by cysteine as a survival mechanism for triple-negative breast cancer cells. | Oncogene | 2024 | 38600165 | PubTator, text mining | PubMed |
| Identification of fatty acid oxidation-related subtypes by integrated analysis of bulk- and single-cell transcriptome profiling in colorectal cancer. | J Gastrointest Oncol | 2024 | 38482228 | PubTator, text mining | PubMed |
| Decoding selectivity: computational insights into AKR1B1 and AKR1B10 inhibition. | Phys Chem Chem Phys | 2024 | 38469695 | PubTator, text mining | PubMed |
| Aldo-keto reductase 1B10 as a Carcinogenic but Not a Prognostic Factor in Colorectal Cancer. | J Cancer | 2024 | 38370384 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57016/papers?page=7